Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Systematic Review of Published Case Studies
View ORCID ProfileDavid E. Gard, Mollie M. Pleet, Ellen R. Bradley, Andrew Penn, Matthew L. Gallenstein, Lauren S. Riley, Meghan DellaCrosse, Emily Garfinkle, Erin E. Michalak, Joshua D. Woolley
doi: https://doi.org/10.1101/2021.04.02.21254838
David E. Gard
aSan Francisco State University, San Francisco, CA USA
Mollie M. Pleet
bUniversity of California San Francisco, San Francisco, CA USA
cSan Francisco Veteran’s Affairs Medical Center, San Francisco, CA USA
Ellen R. Bradley
bUniversity of California San Francisco, San Francisco, CA USA
cSan Francisco Veteran’s Affairs Medical Center, San Francisco, CA USA
Andrew Penn
bUniversity of California San Francisco, San Francisco, CA USA
Matthew L. Gallenstein
aSan Francisco State University, San Francisco, CA USA
Lauren S. Riley
aSan Francisco State University, San Francisco, CA USA
Meghan DellaCrosse
dThe Wright Institute, Berkeley, CA USA
Emily Garfinkle
ePalo Alto University-Pacific Graduate School of Psychology, Palo Alto, CA USA
Erin E. Michalak
fUniversity of British Columbia, Vancouver, BC Canada
Joshua D. Woolley
bUniversity of California San Francisco, San Francisco, CA USA
cSan Francisco Veteran’s Affairs Medical Center, San Francisco, CA USA
Data Availability
Not applicable
Posted April 07, 2021.
Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Systematic Review of Published Case Studies
David E. Gard, Mollie M. Pleet, Ellen R. Bradley, Andrew Penn, Matthew L. Gallenstein, Lauren S. Riley, Meghan DellaCrosse, Emily Garfinkle, Erin E. Michalak, Joshua D. Woolley
medRxiv 2021.04.02.21254838; doi: https://doi.org/10.1101/2021.04.02.21254838
Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Systematic Review of Published Case Studies
David E. Gard, Mollie M. Pleet, Ellen R. Bradley, Andrew Penn, Matthew L. Gallenstein, Lauren S. Riley, Meghan DellaCrosse, Emily Garfinkle, Erin E. Michalak, Joshua D. Woolley
medRxiv 2021.04.02.21254838; doi: https://doi.org/10.1101/2021.04.02.21254838
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2975)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12834)
- Forensic Medicine (12)
- Gastroenterology (835)
- Genetic and Genomic Medicine (4632)
- Geriatric Medicine (425)
- Health Economics (733)
- Health Informatics (2950)
- Health Policy (1075)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4426)
- Nursing (238)
- Nutrition (653)
- Oncology (2301)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (504)
- Public and Global Health (7019)
- Radiology and Imaging (1552)
- Respiratory Medicine (923)
- Rheumatology (447)
- Sports Medicine (386)
- Surgery (492)
- Toxicology (60)
- Transplantation (213)
- Urology (185)